Shenghui Qin

699 total citations
27 papers, 476 citations indexed

About

Shenghui Qin is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Shenghui Qin has authored 27 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Cancer Research and 10 papers in Molecular Biology. Recurrent topics in Shenghui Qin's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Ferroptosis and cancer prognosis (3 papers). Shenghui Qin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Ferroptosis and cancer prognosis (3 papers). Shenghui Qin collaborates with scholars based in China, United States and Taiwan. Shenghui Qin's co-authors include Gavin Y. Wang, Bradley A. Schulte, Kenneth D. Tew, Lingzhi Qin, Stephen P. Ethier, Liwei Liu, Jun Liu, Wei Zhao, Yijie Huang and Wen Yu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Shenghui Qin

24 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenghui Qin China 12 297 156 108 74 56 27 476
Jeremy Soon Kiat Chan Singapore 11 264 0.9× 161 1.0× 106 1.0× 33 0.4× 61 1.1× 13 499
Chien-Yu Chen United States 5 314 1.1× 157 1.0× 86 0.8× 40 0.5× 39 0.7× 7 475
Yanyan Wang China 11 438 1.5× 205 1.3× 70 0.6× 69 0.9× 39 0.7× 32 576
Zhen Cai China 7 475 1.6× 149 1.0× 81 0.8× 48 0.6× 62 1.1× 9 593
Caixia Wang China 14 281 0.9× 168 1.1× 64 0.6× 103 1.4× 31 0.6× 30 491
Ruipu Sun China 10 232 0.8× 98 0.6× 85 0.8× 44 0.6× 58 1.0× 11 396
Che-Chia Hsu United States 6 387 1.3× 145 0.9× 91 0.8× 50 0.7× 70 1.3× 10 504
Wenguang Xu China 13 188 0.6× 127 0.8× 111 1.0× 69 0.9× 65 1.2× 28 439
Xiaohan Qu China 13 375 1.3× 284 1.8× 63 0.6× 55 0.7× 41 0.7× 29 562
Chie Nakashima Japan 17 348 1.2× 215 1.4× 143 1.3× 81 1.1× 54 1.0× 43 607

Countries citing papers authored by Shenghui Qin

Since Specialization
Citations

This map shows the geographic impact of Shenghui Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenghui Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenghui Qin more than expected).

Fields of papers citing papers by Shenghui Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenghui Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenghui Qin. The network helps show where Shenghui Qin may publish in the future.

Co-authorship network of co-authors of Shenghui Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Shenghui Qin. A scholar is included among the top collaborators of Shenghui Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenghui Qin. Shenghui Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yang, Shenghui Qin, Jing Xiong, et al.. (2025). Analysis of tumor cell proliferation (Ki-67) and cell cycle regulator proteins in lung adenocarcinoma with different radiological subtypes. Respiratory Research. 26(1). 138–138.
4.
Ye, Fan, Shaojie Hu, Baoyi Wang, et al.. (2022). Distinct cellular immune profiles in lung adenocarcinoma manifesting as pure ground glass opacity versus solid nodules. Journal of Cancer Research and Clinical Oncology. 149(7). 3775–3788. 9 indexed citations
5.
Li, Chang, Shenghui Qin, Wen Yu, et al.. (2022). Overcoming the blood-brain barrier: Exosomes as theranostic nanocarriers for precision neuroimaging. Journal of Controlled Release. 349. 902–916. 59 indexed citations
6.
Wang, Zhihao, Yusi Liu, Xi Wang, et al.. (2022). A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients. Aging. 14(13). 5571–5589. 1 indexed citations
8.
Wang, Zhihao, Qing Yang, Lingzhi Qin, et al.. (2021). Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes. Cancer Cell International. 21(1). 219–219. 33 indexed citations
9.
Qin, Shenghui, Xiaoyuan He, Bradley A. Schulte, et al.. (2021). Nrf2 inhibition sensitizes breast cancer stem cells to ionizing radiation via suppressing DNA repair. Free Radical Biology and Medicine. 169. 238–247. 45 indexed citations
10.
Du, Guoqiang, et al.. (2020). Analysis of protective immune responses to seasonal influenza vaccination in HIV-infected individuals. Human Vaccines & Immunotherapeutics. 17(1). 124–132. 3 indexed citations
11.
Zhong, Guang‐Xian, Shenghui Qin, Danyelle M. Townsend, et al.. (2019). Oxidative stress induces senescence in breast cancer stem cells. Biochemical and Biophysical Research Communications. 514(4). 1204–1209. 50 indexed citations
12.
Qin, Shenghui, Bradley A. Schulte, & Gavin Y. Wang. (2018). Role of senescence induction in cancer treatment. World Journal of Clinical Oncology. 9(8). 180–187. 34 indexed citations
13.
Qin, Shenghui, et al.. (2017). MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer. Cancer Research. 77(23). 6641–6650. 90 indexed citations
14.
Liu, Liwei, et al.. (2017). miR-223 promotes colon cancer by directly targeting p120 catenin. Oncotarget. 8(38). 63764–63779. 24 indexed citations
15.
Zhang, Chao, Shenghui Qin, Lingzhi Qin, et al.. (2016). Cigarette smoke extract-induced p120-mediated NF-κB activation in human epithelial cells is dependent on the RhoA/ROCK pathway. Scientific Reports. 6(1). 23131–23131. 24 indexed citations
16.
Liu, Liwei, et al.. (2015). Expressions of E-cadherin, p120ctn, β-catenin and NF-κB in ulcerative colitis. Journal of Huazhong University of Science and Technology [Medical Sciences]. 35(3). 368–373. 12 indexed citations
17.
Qin, Shenghui, et al.. (2015). p120‐Catenin modulating nuclear factor‐κB activation is partially RhoA/ROCKdependent in scratch injury. Wound Repair and Regeneration. 23(2). 231–240. 11 indexed citations
18.
Li, Tong‐Fei, et al.. (2015). p120-catenin participates in the progress of gastric cancer through regulating the Rac1 and Pak1 signaling pathway. Oncology Reports. 34(5). 2357–2364. 6 indexed citations
19.
Jin, Yan, Chao Zhang, Shenghui Qin, et al.. (2014). Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis.. PubMed. 7(11). 7999–8007. 33 indexed citations
20.
Dai, Jun, Jinyu Wang, Lili Yang, et al.. (2014). Correlation of Forkhead Box c2 with subtypes and invasive ability of invasive breast cancer. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(6). 896–901. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026